5-α reductase inhibitors and prostate cancer prevention: where do we turn now?

BMC Med · 2011 · PMC3180399 · PMID 21920036

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This change did not reach statistical significance, and prescriptions could not be classified by intended use (prostate cancer prevention vs. treatment of BPH).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.